Determinants of adherence to insulin and blood glucose monitoring among adolescents and young adults with type 1 diabetes in Qatar: a qualitative study.

adherence adolescent blood glucose monitoring insulin qualitative research. type 1 diabetes young adult

Journal

F1000Research
ISSN: 2046-1402
Titre abrégé: F1000Res
Pays: England
ID NLM: 101594320

Informations de publication

Date de publication:
2022
Historique:
accepted: 16 02 2024
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 22 3 2024
Statut: epublish

Résumé

Adherence to insulin and blood glucose monitoring (BGM) is insufficient in adolescents and young adults (AYAs) with type 1 diabetes (T1D) worldwide and in Qatar. Little is known about the factors related to being aware of suboptimal adherence and the beliefs related to suboptimal adherence in this group. This qualitative study investigated factors related to awareness of, and beliefs about suboptimal adherence, as well as the existence of specific action plans to combat suboptimal adherence using the I-Change model. The target group was comprised of 20 Arab AYAs (17-24 years of age) with T1D living in Qatar. Participants were interviewed via semi-structured, face-to-face individual interviews, which were audio-recorded, transcribed verbatim, and analyzed using the Framework Method. Suboptimal adherence to insulin, and particularly to BGM, in AYAs with T1D was identified. Some AYAs reported to have little awareness about the consequences of their suboptimal adherence and how this can adversely affect optimal diabetes management. Participants also associated various disadvantages to adherence ( Interventions that increase awareness concerning the risks of suboptimal adherence of AYAs with T1D are needed, that increase motivation to adhere by stressing the advantages, creating support and increasing self-efficacy, and that address action planning and goal parameters.

Sections du résumé

Background UNASSIGNED
Adherence to insulin and blood glucose monitoring (BGM) is insufficient in adolescents and young adults (AYAs) with type 1 diabetes (T1D) worldwide and in Qatar. Little is known about the factors related to being aware of suboptimal adherence and the beliefs related to suboptimal adherence in this group. This qualitative study investigated factors related to awareness of, and beliefs about suboptimal adherence, as well as the existence of specific action plans to combat suboptimal adherence using the I-Change model.
Methods UNASSIGNED
The target group was comprised of 20 Arab AYAs (17-24 years of age) with T1D living in Qatar. Participants were interviewed via semi-structured, face-to-face individual interviews, which were audio-recorded, transcribed verbatim, and analyzed using the Framework Method.
Results UNASSIGNED
Suboptimal adherence to insulin, and particularly to BGM, in AYAs with T1D was identified. Some AYAs reported to have little awareness about the consequences of their suboptimal adherence and how this can adversely affect optimal diabetes management. Participants also associated various disadvantages to adherence (
Conclusions UNASSIGNED
Interventions that increase awareness concerning the risks of suboptimal adherence of AYAs with T1D are needed, that increase motivation to adhere by stressing the advantages, creating support and increasing self-efficacy, and that address action planning and goal parameters.

Identifiants

pubmed: 38515508
doi: 10.12688/f1000research.123468.2
pmc: PMC10955191
doi:

Banques de données

figshare
['10.6084/m9.figshare.20368068.v2']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

907

Informations de copyright

Copyright: © 2024 AlBurno H et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Auteurs

Hanan AlBurno (H)

Care and Public Health Research Institute, Maastricht University, Maastricht, P.O. Box 616, The Netherlands.

Francine Schneider (F)

Care and Public Health Research Institute, Maastricht University, Maastricht, P.O. Box 616, The Netherlands.

Hein de Vries (H)

Care and Public Health Research Institute, Maastricht University, Maastricht, P.O. Box 616, The Netherlands.

Dabia Al Mohannadi (D)

Endocrinology and Diabetes Department, Hamad Medical Corporation, Doha, P.O. Box 3050, Qatar.

Liesbeth Mercken (L)

Care and Public Health Research Institute, Maastricht University, Maastricht, P.O. Box 616, The Netherlands.
Department of Health Psychology, Open University of the Netherlands, Heerlen, P.O. Box 2960, The Netherlands.

Classifications MeSH